StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/305% above fair value
$550.20−0.42 (-0.08%)

Close on Nov 12, 2026Market cap $7.16BP/E 26.3Yield 0.40%

Chemed cash

Cash and short-term investments held at the end of each period.

Chemed's cash was $48.43M at Sep 30, 2026. For fiscal 2025 it was $74.52M, down 58.2% from the year before. Over ten years it grew 17.6% a year on average. The highest annual figure on record is $263.96M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$74.52M-58.2%
FY2024Dec 31, 2024$178.35M-32.4%
FY2023Dec 31, 2023$263.96M+256.1%
FY2022Dec 31, 2022$74.13M+125.3%
FY2021Dec 31, 2021$32.90M-79.8%
FY2020Dec 31, 2020$162.68M+2541.7%
FY2019Dec 31, 2019$6.16M+27.5%
FY2018Dec 31, 2018$4.83M-56.6%
FY2017Dec 31, 2017$11.12M-27.4%
FY2016Dec 31, 2016$15.31M+4.0%
FY2015Dec 31, 2015$14.73M+4.2%
FY2014Dec 31, 2014$14.13M-83.3%
FY2013Dec 31, 2013$84.42M+21.4%
FY2012Dec 31, 2012$69.53M+82.6%
FY2011Dec 31, 2011$38.08M-23.7%
FY2010Dec 31, 2010$49.92M-55.6%
FY2009Dec 31, 2009$112.42M+2998.6%
FY2008Dec 31, 2008$3.63M-27.3%
FY2007Dec 31, 2007$4.99M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$48.43M-62.7%
Q2 FY2026Jun 30, 2026$40.22M-83.9%
Q1 FY2026Mar 31, 2026$16.86M-90.3%
Q4 FY2025Dec 31, 2025$74.52M-58.2%
Q3 FY2025Sep 30, 2025$129.75M-45.6%
Q2 FY2025Jun 30, 2025$249.90M+12.1%
Q1 FY2025Mar 31, 2025$173.88M-44.5%
Q4 FY2024Dec 31, 2024$178.35M-32.4%
Q3 FY2024Sep 30, 2024$238.45M+37.7%
Q2 FY2024Jun 30, 2024$222.90M+39.4%
Q1 FY2024Mar 31, 2024$313.35M+439.8%
Q4 FY2023Dec 31, 2023$263.96M+256.1%
Q3 FY2023Sep 30, 2023$173.15M+2125.3%
Q2 FY2023Jun 30, 2023$159.92M+1559.0%
Q1 FY2023Mar 31, 2023$58.05M+219.7%
Q4 FY2022Dec 31, 2022$74.13M+125.3%
Q3 FY2022Sep 30, 2022$7.78M-72.9%
Q2 FY2022Jun 30, 2022$9.64M-89.5%
Q1 FY2022Mar 31, 2022$18.16M-91.4%
Q4 FY2021Dec 31, 2021$32.90M-79.8%
Q3 FY2021Sep 30, 2021$28.74M-74.5%
Q2 FY2021Jun 30, 2021$92.12M+352.1%
Q1 FY2021Mar 31, 2021$210.16M+625.9%
Q4 FY2020Dec 31, 2020$162.68M+2541.7%
Q3 FY2020Sep 30, 2020$112.77M+1143.8%
Q2 FY2020Jun 30, 2020$20.38M+513.2%
Q1 FY2020Mar 31, 2020$28.95M+230.2%
Q4 FY2019Dec 31, 2019$6.16M+27.5%
Q3 FY2019Sep 30, 2019$9.07M-86.6%
Q2 FY2019Jun 30, 2019$3.32M-73.8%
Q1 FY2019Mar 31, 2019$8.77M-35.9%
Q4 FY2018Dec 31, 2018$4.83M-56.6%
Q3 FY2018Sep 30, 2018$67.46M+257.5%
Q2 FY2018Jun 30, 2018$12.67M-7.9%
Q1 FY2018Mar 31, 2018$13.69M-70.9%
Q4 FY2017Dec 31, 2017$11.12M-27.4%
Q3 FY2017Sep 30, 2017$18.87M–
Q2 FY2017Jun 30, 2017$13.75M–
Q1 FY2017Mar 31, 2017$47.05M–
Q4 FY2016Dec 31, 2016$15.31M–

More Chemed figures

See a number that looks wrong?